|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Catabasis Pharmaceuticals (NASDAQ: CATB) through any online brokerage.
The latest price target for Catabasis Pharmaceuticals (NASDAQ: CATB) was reported by Ladenburg Thalmann on May 12, 2021. The analyst firm set a price target for 6.00 expecting CATB to rise to within 12 months (a possible 248.84% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Catabasis Pharmaceuticals (NASDAQ: CATB) is $1.72 last updated Today at 8:00:01 PM.
There are no upcoming dividends for Catabasis Pharmaceuticals.
Catabasis Pharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for Catabasis Pharmaceuticals.
Catabasis Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.